Skip to main content
Top
Published in: Tumor Biology 6/2012

01-12-2012 | Research Article

Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells

Authors: Rie Fukui, Eriko Tanabe, Misaho Kitayoshi, Kyohei Yoshikawa, Nobuyuki Fukushima, Toshifumi Tsujiuchi

Published in: Tumor Biology | Issue 6/2012

Login to get access

Abstract

Lysophosphatidic acid (LPA) mediates a wide range of biological responses with G protein-coupled transmembrane receptors (LPA receptors). So far, at least six types of LPA receptors (LPA receptor-1 (LPA1) to LPA6) have been identified. Recently, it has been reported that LPA3 indicates opposite effects on cellular functions of cancer cells. In the present study, to assess a biological role of LPA3 on cell migration ability of colon cancer cells, we generated LPA receptor-3 (LPAR3) knockdown (HCT-sh3-3) cells from HCT116 and measured cell motile and invasion activities. In motility assay with a cell culture insert, HCT-sh3-3 cells showed significantly high cell motile activity, compared with control cells. For invasion assay, the filter was coated with Matrigel. The invasive activity of HCT-sh3-3 cells was significantly higher than that of control cells. Furthermore, we also examined the effects of LPAR3 knockdown on the interaction between colon cancer cells and endothelial F-2 cells. When F-2 cells were cultured with serum-free DMEM containing a supernatant from HCT-sh3-3 cells, the cell growth rate and migration activity of F-2 cells were significantly stimulated, associating with the elevated expressions of vascular endothelial growth factor (VEGF)-A and VEGF-C genes in HCT-sh3-3 cells. These results suggest that LPA3 may act as a negative regulator on cell motile and invasive abilities of colon cancer HCT116 cells.
Literature
1.
go back to reference Lin M-E, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 2010;91:130–8.PubMedCrossRef Lin M-E, Herr DR, Chun J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Prostaglandins Other Lipid Mediat. 2010;91:130–8.PubMedCrossRef
2.
go back to reference Ishii I, Fukushima N, Ye X, Chun J. Lysophospholipid receptors: signaling and biology. Annu Rev Biochem. 2004;73:321–54.PubMedCrossRef Ishii I, Fukushima N, Ye X, Chun J. Lysophospholipid receptors: signaling and biology. Annu Rev Biochem. 2004;73:321–54.PubMedCrossRef
3.
go back to reference Contos JJA, Ishii I, Chun J. Lysophosphatidic acid receptors. Mol Pharmacol. 2000;58:1188–96.PubMed Contos JJA, Ishii I, Chun J. Lysophosphatidic acid receptors. Mol Pharmacol. 2000;58:1188–96.PubMed
4.
go back to reference Furui T, LaPushin R, Mao M, Khan H, Watt SR, Watt MAV. Overexpression of Edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin Canc Res. 1999;5:4308–18. Furui T, LaPushin R, Mao M, Khan H, Watt SR, Watt MAV. Overexpression of Edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin Canc Res. 1999;5:4308–18.
5.
go back to reference Shida D, Watanabe T, Aoki J, Hama K, Kitayama J, Sonoda H, et al. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Investig. 2004;84:1352–62.PubMedCrossRef Shida D, Watanabe T, Aoki J, Hama K, Kitayama J, Sonoda H, et al. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Lab Investig. 2004;84:1352–62.PubMedCrossRef
6.
go back to reference Schulte KM, Beyer A, Kohrer K, Oberhauser S, Roher HD. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer. Int J Cancer. 2001;92:249–56.PubMedCrossRef Schulte KM, Beyer A, Kohrer K, Oberhauser S, Roher HD. Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer. Int J Cancer. 2001;92:249–56.PubMedCrossRef
7.
go back to reference Tsujino M, Fujii M, Okabe K, Mori T, Fukushima N, Tsujiuchi T. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells. Virchows Arch. 2010;457:669–76.PubMedCrossRef Tsujino M, Fujii M, Okabe K, Mori T, Fukushima N, Tsujiuchi T. Differential expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in human colon cancer cells. Virchows Arch. 2010;457:669–76.PubMedCrossRef
8.
go back to reference Tsujiuchi T, Shimizu K, Onishi M, Sugata E, Fujii H, Mori T, et al. Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines. Biochem Biophys Res Commun. 2006;349:1151–5.PubMedCrossRef Tsujiuchi T, Shimizu K, Onishi M, Sugata E, Fujii H, Mori T, et al. Involvement of aberrant DNA methylation on reduced expression of lysophosphatidic acid receptor-1 gene in rat tumor cell lines. Biochem Biophys Res Commun. 2006;349:1151–5.PubMedCrossRef
9.
go back to reference Okabe K, Hayashi M, Wakabayashi N, Yamawaki Y, Teranishi M, Fukushima N, et al. Different expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in mouse tumor cells. Pathobiology. 2010;77:278–82.PubMedCrossRef Okabe K, Hayashi M, Wakabayashi N, Yamawaki Y, Teranishi M, Fukushima N, et al. Different expressions and DNA methylation patterns of lysophosphatidic acid receptor genes in mouse tumor cells. Pathobiology. 2010;77:278–82.PubMedCrossRef
10.
go back to reference Yu S, Murph MM, Lu Y, liu S, Hall HS, Liu J, et al. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Canc Inst. 2008;100:1630–42.CrossRef Yu S, Murph MM, Lu Y, liu S, Hall HS, Liu J, et al. Lysophosphatidic acid receptors determine tumorigenicity and aggressiveness of ovarian cancer cells. J Natl Canc Inst. 2008;100:1630–42.CrossRef
11.
go back to reference Okabe K, Hayashi M, Kato K, Okumura M, Fukui R, Honoki K, et al. Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells. Mol Carcinog. 2012. doi:10.1002/mc.21851. Okabe K, Hayashi M, Kato K, Okumura M, Fukui R, Honoki K, et al. Lysophosphatidic acid receptor-3 increases tumorigenicity and aggressiveness of rat hepatoma RH7777 cells. Mol Carcinog. 2012. doi:10.​1002/​mc.​21851.
12.
go back to reference Hayashi M, Okabe K, Kato K, Okumura M, Fukui R, Honoki K, et al. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett. 2012;316:91–6.PubMedCrossRef Hayashi M, Okabe K, Kato K, Okumura M, Fukui R, Honoki K, et al. Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells. Cancer Lett. 2012;316:91–6.PubMedCrossRef
13.
go back to reference Hayashi M, Okabe K, Yamawaki Y, Teranishi M, Honoki K, Mori T, et al. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells. Biochem Biophys Res Commun. 2011;405:450–4.PubMedCrossRef Hayashi M, Okabe K, Yamawaki Y, Teranishi M, Honoki K, Mori T, et al. Loss of lysophosphatidic acid receptor-3 enhances cell migration in rat lung tumor cells. Biochem Biophys Res Commun. 2011;405:450–4.PubMedCrossRef
14.
go back to reference Shida D, Kitayama J, Yanaguchi H, Okaji Y, Tsuno NH, Watanabe T, et al. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 2003;63:1706–11.PubMed Shida D, Kitayama J, Yanaguchi H, Okaji Y, Tsuno NH, Watanabe T, et al. Lysophosphatidic acid (LPA) enhances the metastatic potential of human colon carcinoma DLD1 cells through LPA1. Cancer Res. 2003;63:1706–11.PubMed
15.
go back to reference Okabe K, Kato K, Teranishi M, Okumura M, Fukui R, Mori T, et al. Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells. Cancer Lett. 2011;309:236–42.PubMedCrossRef Okabe K, Kato K, Teranishi M, Okumura M, Fukui R, Mori T, et al. Induction of lysophosphatidic acid receptor-3 by 12-O-tetradecanoylphorbol-13-acetate stimulates cell migration of rat liver cells. Cancer Lett. 2011;309:236–42.PubMedCrossRef
16.
go back to reference Shano S, Hatanaka K, Ninose S, Moriyama R, Tsujiuchi T, Fukushima N. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim Biophys Acta. 2008;1783:748–59.PubMedCrossRef Shano S, Hatanaka K, Ninose S, Moriyama R, Tsujiuchi T, Fukushima N. A lysophosphatidic acid receptor lacking the PDZ-binding domain is constitutively active and stimulates cell proliferation. Biochim Biophys Acta. 2008;1783:748–59.PubMedCrossRef
17.
go back to reference Kato K, Fukui R, Okabe K, Tanabe E, Kitayoshi M, Fukushima N, et al. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2. Biochem Biophys Res Commun. 2012;417:790–3.PubMedCrossRef Kato K, Fukui R, Okabe K, Tanabe E, Kitayoshi M, Fukushima N, et al. Constitutively active lysophosphatidic acid receptor-1 enhances the induction of matrix metalloproteinase-2. Biochem Biophys Res Commun. 2012;417:790–3.PubMedCrossRef
18.
go back to reference Tei K, K-Kimura N, Taguchi O, Kumamoto K, Higashiyama S, Taniguchi N, et al. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res. 2002;62:6289–96.PubMed Tei K, K-Kimura N, Taguchi O, Kumamoto K, Higashiyama S, Taniguchi N, et al. Roles of cell adhesion molecules in tumor angiogenesis induced by cotransplantation of cancer and endothelial cells to nude rats. Cancer Res. 2002;62:6289–96.PubMed
19.
go back to reference Kitayoshi M, Kato K, Tanabe E, Yoshikawa K, Fukui R, Fukushima N, et al. Enhancement of endothelial cell migration by constitutively active LPA1-expressing tumor cells. Biochem Biophys Res Commun. 2012;422:339–43.PubMedCrossRef Kitayoshi M, Kato K, Tanabe E, Yoshikawa K, Fukui R, Fukushima N, et al. Enhancement of endothelial cell migration by constitutively active LPA1-expressing tumor cells. Biochem Biophys Res Commun. 2012;422:339–43.PubMedCrossRef
20.
go back to reference Aoki J, Inoue A, Okudaira S. Two pathways for lysophosphatidic acid production. Biochim Biophys Acta. 2008;1781:513–8.PubMedCrossRef Aoki J, Inoue A, Okudaira S. Two pathways for lysophosphatidic acid production. Biochim Biophys Acta. 2008;1781:513–8.PubMedCrossRef
21.
22.
23.
go back to reference Hu Y-L, Albanese C, Pestell RG, Jaffe RB. Dual mechanisms for lysophosphatidic acid stimulation on human ovarian carcinoma cells. J Natl Canc Inst. 2003;95:733–40.CrossRef Hu Y-L, Albanese C, Pestell RG, Jaffe RB. Dual mechanisms for lysophosphatidic acid stimulation on human ovarian carcinoma cells. J Natl Canc Inst. 2003;95:733–40.CrossRef
24.
go back to reference Lin C-I, Chen C-N, Huang M-T, Lee S-J, Lin C-H, Chang C-C, et al. Lyophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA1/3, COX-2, and NF-κB activation- and EGFR transactivation-dependent mechanisms. Cell Signal. 2008;20:1804–14.PubMedCrossRef Lin C-I, Chen C-N, Huang M-T, Lee S-J, Lin C-H, Chang C-C, et al. Lyophosphatidic acid upregulates vascular endothelial growth factor-C and tube formation in human endothelial cells through LPA1/3, COX-2, and NF-κB activation- and EGFR transactivation-dependent mechanisms. Cell Signal. 2008;20:1804–14.PubMedCrossRef
25.
go back to reference Kitayoshi M, Fukui R, Tanabe E, Kato K, Yoshikawa K, Fukushima N, et al. Different effects on cell proliferation and migration abilities of endothelial cells by LPA1 and LPA3 in mammary tumor FM3A cells. J Recept Signal Transduct. 2012. doi:10.3109/10799893.2012.692121. Kitayoshi M, Fukui R, Tanabe E, Kato K, Yoshikawa K, Fukushima N, et al. Different effects on cell proliferation and migration abilities of endothelial cells by LPA1 and LPA3 in mammary tumor FM3A cells. J Recept Signal Transduct. 2012. doi:10.​3109/​10799893.​2012.​692121.
26.
go back to reference Zaslavsky A, Singh LS, Tan H, Ding H, Liang Z, Xu Y. Homo- and hetero-dimerization of LPA/SIP receptors, OGR1 and GPR4. Biochim Biophys Acta. 2006;1761:1200–12.PubMedCrossRef Zaslavsky A, Singh LS, Tan H, Ding H, Liang Z, Xu Y. Homo- and hetero-dimerization of LPA/SIP receptors, OGR1 and GPR4. Biochim Biophys Acta. 2006;1761:1200–12.PubMedCrossRef
Metadata
Title
Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells
Authors
Rie Fukui
Eriko Tanabe
Misaho Kitayoshi
Kyohei Yoshikawa
Nobuyuki Fukushima
Toshifumi Tsujiuchi
Publication date
01-12-2012
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 6/2012
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-012-0450-z

Other articles of this Issue 6/2012

Tumor Biology 6/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine